GlassScriptPhysician profile
Anatoly Braylovsky
NPI 1023004124
$3,101.71
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,545 · 2020: $557.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $431.59 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $304.74 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $257.21 | 2019-2020 | |
| Pfizer INC. | $248.84 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $241.54 | 2019-2020 | |
| Amgen INC. | $201.08 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $182.20 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $168.23 | 2019-2020 | |
| Lilly USA, LLC | $158.93 | 2019-2020 | |
| Indivior INC. | $100.32 | 2019-2020 | |
| Amarin Pharma, INC. | $80.91 | 2019-2020 | |
| Orexo US, INC. | $70.96 | 2019-2020 | |
| Daiichi Sankyo INC. | $68.47 | 2019 | |
| Allergan, INC. | $61.57 | 2019-2020 | |
| Insulet Corporation | $61.46 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $55.86 | 2019-2020 | |
| Mdd US Operations, LLC | $39.52 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $36.69 | 2020 | |
| Shire North American Group INC | $35.06 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.30 | 2019 | |
| Kaleo, INC. | $31.75 | 2019 | |
| Janssen Pharmaceuticals, INC | $30.80 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.46 | 2019 | |
| Abbvie INC. | $24.90 | 2019 | |
| Glaxosmithkline, LLC. | $19.75 | 2019 | |
| Ironwood Pharmaceuticals, INC | $19.27 | 2019 | |
| Avanir Pharmaceuticals, INC. | $18.79 | 2019 | |
| Astellas Pharma US INC | $18.44 | 2019 | |
| Seqirus USA INC | $16.37 | 2019 | |
| Assertio Therapeutics, INC. | $14.54 | 2020 | |
| Lupin INC. | $14.43 | 2019 | |
| Oxford Immunotec USA INC | $13.00 | 2019 | |
| Sentynl Therapeutics, INC. | $11.73 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anatoly Braylovsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.